Compare Lamb Weston Holdings Inc (LW) vs Philip Morris International Inc. (PM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lamb Weston Holdings Inc vs Philip Morris International Inc. — how do they compare? Lamb Weston Holdings Inc trades at $47.87 (market cap $6.81B), while Philip Morris International Inc. trades at $201.19 (market cap $312.50B). The key difference: Philip Morris International Inc. is far larger — about 45.9× Lamb Weston Holdings Inc's market cap, and Philip Morris International Inc. pays the higher dividend (3.19%). Which is the better fit depends on your goals — on Pluang, investors hold Lamb Weston Holdings Inc for 66 Days and Philip Morris International Inc. for 85 Days on average.
| LW | PM | |
|---|---|---|
Market Cap | $6.81B | $312.50B |
Volume | 4,638,686 | 5,517,172 |
Sector | Consumer Staples | Consumer Staples |
52-Week High | $66.57 | $201.19 |
52-Week Low | $38.48 | $144.33 |
Typical Hold Time | 66 Days | 85 Days |
Enterprise Value | $10.61B | $355.62B |
Dividend Yield | 3.07% | 3.19% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Lamb Weston (LW) trades at $49.46, up 2.85% today, showing strong momentum with four consecutive earnings beats. The stock maintains a bullish technical signal with support at $49 and resistance at $50. Fundamentals show solid revenue growth from $4.1B in 2022 to $6.45B in 2025, though net margins compressed from 18.85% to 3.85%. Analyst consensus is mixed with 31.58% Buy ratings and a $53.71 price target, representing 8.6% upside potential.
LW offers potential through continued earnings outperformance and margin recovery initiatives, but faces risks from profit margin volatility and ongoing legal scrutiny. The stock's current valuation at 27x P/E appears reasonable given growth prospects, though investors should monitor execution on the Focus to Win cost-saving strategy and resolution of fiduciary investigation concerns.
Philip Morris International (PM) trades at $200.5, up 4.05% on the day, with a bullish technical signal and strong analyst support. Recent Q2 2026 earnings beat expectations, and revenue growth is robust, driven by smoke-free products like IQOS and ZYN. The stock is near its pivot point of $200, with support at $197 and resistance at $203. Cash flow trends show improving operational performance, though debt levels remain elevated.
The outlook is positive due to earnings momentum and smoke-free product expansion, but risks include regulatory pressures and high valuation. Wall Street consensus is bullish with a $212.17 price target, suggesting upside potential. Investors should weigh growth prospects against macroeconomic and industry-specific headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lamb Weston Holdings Inc
Lamb Weston is the world's second-largest producer of branded and private-label frozen potato products, such as French fries, sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips. The company also has a small appetizer business that produces onion rings, mozzarella sticks, and cheese curds. Including joint ventures, 63% of fiscal 2022 revenue was U.S.-based, with the remainder stemming from Europe, Canada, Japan, China, Korea, Mexico, and several other countries. Lamb Weston's customer mix is estimated 58% quick-serve restaurants, 19% full-service restaurants, 8% other food services (hotels, commercial cafeterias, arenas, schools), and 16% retail. Lamb Weston became an independent company in 2016 when it was spun off from Conagra.
Read more on LW →About Philip Morris International Inc.
Philip Morris International is an international tobacco company with a product portfolio primarily consisting of cigarettes and reduced-risk products, including heat-not-burn, vapor and oral nicotine products, which are sold in markets outside the United States. The company diversified away from nicotine products with the acquisition of Vectura, a provider of innovative inhaled drug delivery solutions, in 2021.
Read more on PM →
